Pentixapharm Holding AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.16	4.62	23.23	9.7	1.09	2.39
Short-Term Investments	-	0.34	-	0.53	-	-
Cash & Short-Term Investments	5.16	4.97	23.23	10.23	1.09	2.39
Cash Growth	-70.31%	-78.62%	127.05%	842.17%	-54.50%	-
Accounts Receivable	0.02	0.03	6.81	0.16	0.51	0.01
Other Receivables	0.19	0.6	0.91	8.32	2.25	0.16
Receivables	0.21	0.63	7.71	8.48	2.77	0.17
Other Current Assets	0.96	0.39	0.34	-	-	-
Total Current Assets	6.33	5.99	31.28	18.71	3.85	2.56
Property, Plant & Equipment	0.02	0.04	0.27	0.32	0.33	0.26
Long-Term Investments	-	-	-	-	-	1.32
Goodwill	-	-	-	0.78	0.78	-
Other Intangible Assets	31.37	1.06	0.67	0.81	0.88	0.95
Long-Term Deferred Tax Assets	3.23	3.33	0.92	1.79	1.79	-
Long-Term Deferred Charges	-	31.22	34.69	50.98	46.23	24.06
Other Long-Term Assets	0.22	0.23	0.48	0.01	0.01	-
Total Assets	41.17	41.86	68.3	73.4	53.88	29.15
Accounts Payable	1.86	2.44	8.94	2.54	0.21	0.4
Accrued Expenses	-	0.42	0.6	0.35	0.3	0.07
Current Income Taxes Payable	-	0.08	0.08	-	-	-
Current Unearned Revenue	-	0.18	4.21	5.08	-	-
Other Current Liabilities	1.09	0.35	0.21	1.43	1.34	0.03
Total Current Liabilities	2.94	3.46	14.04	9.4	1.84	0.5
Long-Term Debt	-	-	-	6.3	6.11	-
Long-Term Unearned Revenue	-	-	-	0.34	-	-
Long-Term Deferred Tax Liabilities	3.23	3.33	3.93	8.88	7.45	0.76
Other Long-Term Liabilities	2.84	-	0	0	0	-
Total Liabilities	9.02	6.79	17.97	24.92	15.41	1.26
Common Stock	24.8	24.8	24.8	21.7	0.09	0.09
Retained Earnings	-31.62	-28.44	-11.93	2.13	-0.3	-4.45
Treasury Stock	-0.01	-0.01	-0.01	-	-	-
Comprehensive Income & Other	38.99	38.73	37.48	24.65	38.68	32.25
Shareholders' Equity	32.15	35.07	50.33	48.48	38.47	27.88
Total Liabilities & Equity	41.17	41.86	68.3	73.4	53.88	29.15
Total Debt	-	-	-	6.3	6.11	-
Net Cash (Debt)	5.16	4.97	23.23	3.93	-5.03	2.39
Net Cash Growth	-70.31%	-78.62%	490.54%	-	-	-
Net Cash Per Share	0.21	0.20	0.94	0.18	-	-
Filing Date Shares Outstanding	24.78	24.78	24.78	21.7	-	-
Total Common Shares Outstanding	24.78	24.78	24.78	21.7	-	-
Working Capital	3.39	2.53	17.24	9.31	2.01	2.06
Book Value Per Share	1.30	1.42	2.03	2.23	-	-
Tangible Book Value	0.78	34.01	49.67	46.9	36.81	26.94
Tangible Book Value Per Share	0.03	1.37	2.00	2.16	-	-
Machinery	-	0.11	0.45	0.48	0.44	0.33